Resultados de búsqueda - Samuel Gebhardt
- Mostrando 1 - 1 Resultados de 1
-
1
CD19-CD28: An affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy por Johannes Sam, Thomas Höfer, Christine Kuettel, Christina Claus, Jenny Tosca Thom, Sylvia Herter, Guy Georges, Koorosh Korfi, Martin Lechmann, Miro J. Eigenmann, Daniel Marbach, Candice Jamois, Katharina Lechner, Sreenath M. Krishnan, Brenda Gaillard, Joana Marinho, Sven Kronenberg, Leo Kunz, Sabine Wilson, Stefanie Briner, Samuel Gebhardt, Ahmet Varol, Birte Appelt, Valeria Nicolini, Dario Speziale, M. El Bez, Esther Bommer, Jan Eckmann, Carina Hage, Florian Limani, Silvia Jenni, Anne Schoenle, Marine Le Clech, Jean-Baptiste Pierre Vallier, Sara Colombetti, Marina Bacac, Stephan Gasser, Christian Klein, Pablo Umaña
Publicado 2024Artigo